Compare BridgeBio Pharma Inc (BBIO) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs HP Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while HP Inc trades at $29.12 (market cap $26.59B). The key difference: HP Inc is the larger of the two by market cap, and HP Inc pays a 4.13% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | HPQ | |
|---|---|---|
Market Cap | $16.36B | $26.59B |
Sector | Health | Technology |
52-Week High | $90.17 | $30.05 |
52-Week Low | $47.29 | $18.20 |
Enterprise Value | $18.14B | $33.75B |
Dividend Yield | — | 4.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
